Table 3.
PALN metastases.
| Author/Year | Timing of Presentation, n (%) | Anatomical Location, n (%) | PALN Harvested, Median n (Range) | PALNM, Median n (Range) | ||
|---|---|---|---|---|---|---|
| Synchronous | Metachronous | Type A | Type B | |||
| Min et al./2008 | 0 | 6 (100) | 2 (33.3) | 4 (66.7) | / | / |
| Choi et al./2010 | 19 (79.2) | 5 (20.8) | 0 | 24 (100) | / | / |
| Gagnière et al./2015 | / | / | / | / | / | / |
| Song et al./2016 | 16 (100) | 0 | 0 | 16 (100) | 3.5 (1–17) | 1 (1–17) |
| Ogura et al./2017 | 16 (100) | 0 | 0 | 16 (100) | / | 1 (0–4) |
| Bae et al./2018 | 49 (100) | 0 | 0 | 49 (100) | 6.9 ± 5.2 a | 3.9 ± 4.0 a |
| Yamamoto et al./2019 | 5 (100) | 0 | 0 | 5 (100) | 8 (1–23) | / |
| Kim et al./2020 | 0 | 16 (100) | 0 | 16 (100) | / | 1 (1–6) |
| Sakamoto et al./2020 | 19 (100) | 0 | 0 | 19 (100) | 11 (1–45) | 2 (1–25) |
PALN = Para-aortic lymph node. a = mean.